BAZ BIOMEDIC tries to respond to the new medical and bio industries with the Fourth Industrial Revolution,
that blurs the boundaries between digital, physical, and biological areas. BAZ BIOMEDIC developed automatic repetitive injection
drug delivery technology, commercializing it with affordable price, after striving to the development of the technology since 2011.
Rather than being satisfied with the development, BAZ BIOMEDIC is trying to move forward.
Now, BAZ BIOMEDIC is working on developing small-sized self-injection for skin and health care at home with affordable price.
BAZ BIOMEDIC staff will continuously move forward to be the global leader of the Drug Delivery Technology.
CEO, BAZ BIOMEDIC
Prof. Yoh Jai-ick